Part 2 recipient proceeding-use restriction

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

The live 42 CFR 2.12(d)(1) applies the proceeding and law-enforcement restrictions to every person who obtains a covered record from a Part 2 program, covered entity, business associate, intermediary, or other lawful holder, regardless of that person's status or whether the record was obtained under Part 2's court-order subpart. Section 2.31(d) keeps proceeding consent separate from other consent, and section 2.32 provides the notice and consent-copy requirements for consent-based disclosures. eCFR displays Title 42 as current through August 20, 2026 and last amended August 13, 2026.

Recipient status does not remove the restriction

The current recipient rule applies regardless of who obtained the record and whether the record was obtained under Part 2's court-order subpart. Classify the source, record, recipient, acquisition route, notice, proposed use, target, proceeding, and authority.

The protected uses are broad

The rule addresses criminal charges and investigations, civil and criminal actions, administrative and legislative proceedings, agency decisions, law-enforcement purposes, and warrant applications. Undercover-agent, informant, and patient-access routes also retain the specified restrictions.

Build a use gate after receipt

Tag provenance, preserve accompanying notices, limit access, route subpoenas and government demands, prevent downstream exports, record legal decisions, and keep any consent or court order tied to its person, purpose, record set, recipient, and dates.

Preserve provenance at receipt

Tag the record's source, Part 2 program if known, patient, date received, acquisition route, consent or order, notice, recipient, storage, copies, and downstream systems. Keep the accompanying notice and consent or scope explanation with the record. A generic “medical” label can cause later users to miss the proceeding restriction.

Apply the same control to extracts, testimony, summaries, attachments, exports, analytics, and derived work product that convey covered information. Restrict search, download, sharing, legal hold, and bulk export, and make the escalation route visible to staff who receive subpoenas or government requests.

Screen the proposed use, not only the original receipt

Record the target patient, proposed use, civil, criminal, administrative, or legislative matter, requesting authority, records or testimony, purpose, deadline, and legal basis. The rule addresses introduction into evidence, use in warrants, law-enforcement investigation, agency decision-making, and other ways information may be relied upon against a patient.

Lawful possession does not answer the later-use question. Undercover-agent, informant, and patient-access routes retain the specified restrictions. A recipient's government, court, employer, payer, provider, family, or researcher status does not itself remove them.

Require the right proceeding authority

Route the matter to experienced Part 2 counsel. If patient consent is proposed, verify the current elements, target, record set, purpose, recipient, dates, and section 2.31(d) separation. If an order is proposed, identify the controlling Part 2 provision and match the production to its exact scope. Preserve objections, narrowing, protective terms, and the final decision.

For any approved use, collect from the authoritative source, limit fields and dates, review metadata, verify the recipient, use secure transmission, and retain a production log. Stop downstream use when authority expires, purpose changes, or a new recipient or proceeding appears.

Example

Twelve proposed proceeding uses are assessed. Nine have complete provenance, use, target, authority, scope, and approval evidence; three merely show lawful receipt. Readiness is 9 of 12 uses.

Make the use decision auditable

Classify the proposed use as supported by specific proceeding consent, supported by a matching Part 2 order, narrowed, opposed, denied, or unresolved. Record the target patient, record and testimony scope, proceeding, purpose, recipient, dates, decision-maker, protective terms, and expiration.

Configure the result in the legal hold, review workspace, access groups, production tool, and testimony plan. After the matter ends, remove temporary access, preserve required evidence, apply retention, and confirm that exports and working copies follow the final disposition.

Proceeding-use checklist for recipients

• tag Part 2 provenance, acquisition route, consent or order, notice, and copies;
• screen testimony, summaries, derived output, warrants, investigations, and agency use;
• identify the target patient, proceeding, purpose, requester, scope, and deadline;
• verify separate proceeding consent or the exact Part 2 court-order authority;
• minimize, secure, and log any approved production or testimony; and
• block and escalate later use when authority, purpose, recipient, or scope changes.

This restriction is not satisfied merely by lawful receipt, a subpoena, or a general medical authorization. Current Part 2 provisions, the record's provenance, proceeding facts, HIPAA, state law, and a qualified legal determination control the response.